首页膀胱肿瘤临床实践指南详情

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

原文: 2021 年 发布于 J Immunother Cancer 9 卷 第 7 期 189-196 浏览量:203次

作者: Galsky M. D. Balar A. V. Black P. C. Campbell M. T. Dykstra G. S. Grivas P. Gupta S. Hoimes C. J. Lopez L. P. Meeks J. J. Plimack E. R. Rosenberg J. E. Shore N. Steinberg G. D. Kamat A. M.

作者单位: Center for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region - China. Department of Urology and Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning - China. Department of Urology, the 303rd Hospital of Chinese People's Liberation Army, Nanning - China.

归属分类: 膀胱肿瘤临床实践指南

DOI: 10.2217/imt-2017-0190

关键词: 窄带成像 非肌层浸润性膀胱癌 经尿道膀胱肿瘤电切术 安全性 共识

文献简介

膀胱癌是泌尿系统常见的恶性肿瘤之一,国外统计数据显示其发病率位居全身恶性肿瘤的第11位,死亡率位居第13位[1-2].非肌层浸润性膀胱癌(non muscle-invasive bladder cancer ,NMIBC)约占初诊膀胱癌的75%,其中20% ~30% 会进展为肌层浸润性膀胱癌.在临床分期上,NMIBC局限于黏膜层为 Ta和Tis期,局限于黏膜固有层为T1期[3].

热门文献